Quarterly report · Q3
4323.TEDINET S100STOD
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.6bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥17.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥17.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥15.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.0bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.6bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.1bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥482m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥553m | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥73m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥415m | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥276m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥89.62 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.52 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.5 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.16 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥137m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥137m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥1.5bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥46m |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥331m |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥285m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥407,000 |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥721m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥18.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥137m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥143m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥143m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.2bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥35m |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥277m |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥171m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥42m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥737m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥16.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥16.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥143m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥2.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from collection of guarantee deposits inv cf | Prior1YTDDuration | 25035000 | JPY |
| Proceeds from collection of guarantee deposits inv cf | CurrentYTDDuration | 23763000 | JPY |
| Payments for guarantee deposits inv cf | Prior1YTDDuration | -2659000 | JPY |
| Payments for guarantee deposits inv cf | CurrentYTDDuration | -83082000 | JPY |
| Other net inv cf | Prior1YTDDuration | -1650000 | JPY |
| Other net inv cf | CurrentYTDDuration | 14686000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -72733000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -552772000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -9047000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -20011000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -15487000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | Prior1YTDDuration | 3740000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | CurrentYTDDuration | － | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -439000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -244000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -248274000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -397228000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -1680000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -1752000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -275712000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -414712000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 109804000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 30049000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 243638000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 348707000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6463823000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6793050000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 6707462000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 7141757000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 10392405000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 2996685000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1185412000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 2060715000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 16635219000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 16635219000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 65946000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 42200000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 35299000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 143446000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -143446000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 10458352000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 3038886000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1185412000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 2096015000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 16778665000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -143446000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |